SlideShare a Scribd company logo
1 of 89
Download to read offline
New Hollow Fiber Membranes for
AEX and CEX in Flow-Through Mode
Bixente MARTIRENE, MSc
Senior Product Manager
Asahi Kasei Bioprocess Europe
b.martirene@akbio.eu
8th Annual European BioInnovation Leaders Summit
10th - 11th February 2015
Radisson Blu Edwardian Hotel, London
www.ak-bio.com
1) Pathogen Removal Filters
Content
Introduction
1)  Hollow Fiber Membrane for AEX: QyuSpeed D
2)  Hollow Fiber Membrane Prototype for CEX
3)  Case study:
Combination of CEX Prototype & AEX QyuSpeed D
Conclusion
Foundation: 1931; HQ: Tokyo; Employees: 25 000; Turnover: 16 B$
Asahi Kasei Group
3
PlanovaTM
Virus removal filters
Asahi Kasei Bioprocess
4
PlanovaTM
Virus removal filters
QyuSpeedTM D
AEX adsorber
BioOptimalTM MF-SL
TFF microfilter
Asahi Kasei Bioprocess
5
PlanovaTM
Virus removal filters
QyuSpeedTM D
AEX adsorber
BioOptimalTM MF-SL
TFF microfilter
Systems & Equipment
Asahi Kasei Bioprocess
6
PlanovaTM
Virus removal filters
QyuSpeedTM D
AEX adsorber
BioOptimalTM MF-SL
TFF microfilter
Systems & Equipment
CellufineTM
Cellulose Beads
Chromatography media
(made by JMC Corporation)
Asahi Kasei Bioprocess
7
1) Pathogen Removal Filters
Introduction
9
Why Membrane vs. Resin ?
ü  Mass transfer: “fast” convection vs. “slow” diffusion
ü  5-13 BV*/min vs. 0.5-2 BV/min, low pressure drop
ü  10-20 x higher loading capacity ➔ smaller BV required
ü  Easy setup & operation ≈ Dead-End Filter
Introduction
* : Bed Volume = Column Volume = Membrane Volume
10
Introduction
Feedback from our customers:
ü  Flow-Through mode preferred for ease of use
ü  AEX adsorbers more & more implemented in DSP
ü  CEX mainly performed with classical resins
11
Introduction
Asahi Kasei BioProcess:
ü  QyuSpeed D launched in 2011 for AEX ➔ Success
ü  New Hollow Fiber Membrane for CEX in FT mode ???
1) Pathogen Removal Filters
1)  Hollow Fiber Membrane for AEX: QyuSpeed D
13
QyuSpeed D AEX Adsorber
Inlet
Outlet
QyuSpeed D
Module
14
QyuSpeed D AEX Adsorber
Inlet
Outlet
Hollow fiberQyuSpeed D
Module
Protein solution
with biomolecules -
Protein solution
biomolecules - free
§  Dead-End
filtration
§  Removal of
HCP, DNA,
Virus
15
QyuSpeed D AEX Adsorber
Inside the pore
Grafted chain with
DEA ligands
Biomolecules -
Micropore
0.2-0.3 Âľm
>
16
QyuSpeed D AEX Adsorber
Inside the pore
Grafted chain with
DEA ligands
Biomolecules -
Micropore
0.2-0.3 Âľm
H2C
C-C-O-CH2CHCH2H3C-
=
O HO
NH(CH2CH3)2
+
()
H2C
C-C-O-CH2CHCH2H3C-
=
O HO
()
NH(CH2CH3)2
+
Poly glycidyl methacrylate
Grafted chain
DEA
> >
17
QyuSpeed D AEX Adsorber
ü  Multipoint adsorption
ü  High ligand density
Inside the pore
Grafted chain with
DEA ligands
Biomolecules -
Micropore
0.2-0.3 Âľm
H2C
C-C-O-CH2CHCH2H3C-
=
O HO
NH(CH2CH3)2
+
()
H2C
C-C-O-CH2CHCH2H3C-
=
O HO
()
NH(CH2CH3)2
+
Poly glycidyl methacrylate
Grafted chain
DEA
➔ high DBC & Salt tolerance
> >
18
Product Line-Up
Membrane
(Bed)
Volume	
0.6 mL 150 mL 550 mL 5 L
Maximum
Flow Rate
8 mL/min 2 L/min 8 L/min 60 L/min
0.6 mL	 150 mL	 550 mL	 5 L	
1172 mm
315 mm
19
Innovative Implementation: pre Prot. A
1)  Post Protein A, in place of traditional AEX resin column
2)  Post CEX w/o any prior dilution or buffer change: salt tolerant
Protein A
UFPlanova
CIEX
Centri-
fugation
Tangential MF
Depth
Filtration
or
0.2 Âľm
filtration
20
AEX with
QyuSpeed D
Classical Implementations of QyuSpeed D
10% BSA DBC > 40 g/L-BV
10% DNA DBC @ 15 mS/cm < 30 g/L-BV
HCP reduction
25 – 99 % removal
(depending on pI of HCP)
Parvovirus LRV > 4 Log
MAb Loading capacity
Post Protein A
(in standard flow through mode)
> 2000 g/L-BV
(depending on quantities of impurities)
Number of regenerations
> 10
(tested up to 100 x with BSA)
21
Performances
22
Advantages vs. other AEX Adsorbers
ü  Same membrane for low or high conductivity solutions
ü  “flexible” implementation: pre or post Prot. A, pre or post CEX
ü  Single-use or Reusable (1M NaCl; 1N NaOH)
23
2)  Hollow Fiber Membrane Prototype for CEX
24
2)  Hollow Fiber Membrane Prototype for CEX
➔ CEX in FT mode
25
New QyuSpeed Prototype for CEX
Inlet
Lab module
Outlet
26
New QyuSpeed Prototype for CEX
Inlet
§  Flow Through
mode = Dead-
End filtration
§  Removal of
Aggregates,
Prot. A, HCP
Outlet
Lab module
27
New QyuSpeed Prototype for CEX
Inlet
Hollow fiber
Protein solution
with aggregates
Protein solution
aggregate free
Outlet
Lab module
§  Flow Through
mode = Dead-
End filtration
§  Removal of
Aggregates,
Prot. A, HCP
28
Inside the pore
Grafted chain with
3 different ligands
Aggregate
Micropore
0.2-0.3 Âľm
>
New QyuSpeed Prototype for CEX
29
Inside the pore
Grafted chain with
3 different ligands
Aggregate
Micropore
0.2-0.3 Âľm
Grafted chain
> >
New QyuSpeed Prototype for CEX
-R1
	
-R2	
-R3	
R1, R2 & R3 are side chains with different ligands & interactions
30
Aggregate Removal vs. pH
31
Aggregate Removal vs. pH
Feed solution: MAb (h-IgG1), 5 mg/mL, pI 8.4
Buffer: 15 mM Tris-HCl
Conductivity: 1.4 mS/cm
Loading: ~ 1 000 g/L-membrane volume (BV)
Flow rate: 6 BV/min
Aggregate content: ~ 5 %
32
Aggregate Removal vs. pH
Feed solution: MAb (h-IgG1), 5 mg/mL, pI 8.4
Buffer: 15 mM Tris-HCl
Conductivity: 1.4 mS/cm
Loading: ~ 1 000 g/L-membrane volume (BV)
Flow rate: 6 BV/min
Aggregate content: ~ 5 %
pH 7.0 pH 7.5 pH 8.0
Feed
solution	
Monomer (%) 94.73 94.51 93.54
Dimer (%) 2.25 2.76 3.58
≧ Trimer (%) 3.02 2.73 2.88
33
Aggregate Removal vs. pH
pH 7.0 pH 7.5 pH 8.0
34
Aggregate Removal vs. pH
pH 7.0 pH 7.5 pH 8.0
pH 7.0 pH 7.5 pH 8.0
Monomer recovery (%) 88.87 92.2 93.07
35
Aggregate Removal vs. pH
pH 7.0 pH 7.5 pH 8.0
pH 7.0 pH 7.5 pH 8.0
Monomer recovery (%) 88.87 92.2 93.07
Flow Through	
(reduction %)
Monomer (%) 97.42
Dimer (%) 1.34 (49)
≧ Trimer (%) 1.24 (65)
36
Aggregate Removal vs. pH
pH 7.0 pH 7.5 pH 8.0
pH 7.0 pH 7.5 pH 8.0
Monomer recovery (%) 88.87 92.2 93.07
Flow Through	
(reduction %)
Monomer (%) 97.42 98.65
Dimer (%) 1.34 (49) 1.10 (65)
≧ Trimer (%) 1.24 (65) 0.25 (92)
37
Aggregate Removal vs. pH
pH 7.0 pH 7.5 pH 8.0
pH 7.0 pH 7.5 pH 8.0
Monomer recovery (%) 88.87 92.2 93.07
Flow Through	
(reduction %)
Monomer (%) 97.42 98.65 97.98
Dimer (%) 1.34 (49) 1.10 (65) 1.74 (57)
≧ Trimer (%) 1.24 (65) 0.25 (92) 0.28 (91)
38
Aggregate Removal vs. pH
pH 7.0 pH 7.5 pH 8.0
pH 7.0 pH 7.5 pH 8.0
Monomer recovery (%) 88.87 92.2 93.07
Flow Through	
(reduction %)
Monomer (%) 97.42 98.65 97.98
Dimer (%) 1.34 (49) 1.10 (65) 1.74 (57)
≧ Trimer (%) 1.24 (65) 0.25 (92) 0.28 (91)
39
Aggregate Removal vs. Cond.
40
Aggregate Removal vs. Cond.
1.4 mS/cm 2.6 mS/cm 4.7 mS/cm
41
Conductivity (mS/cm)	 1.4 2.6 4.7
Monomer recovery (%) 88.87 92.32 89.12
Flow Through	
(reduction %)
Monomer (%) 97.42 99.48 98.59
Dimer (%) 1.34 (49) 0.39 (78) 1.03 (60)
≧ Trimer (%) 1.24 (65) 0.13 (95) 0.38 (86)
Aggregate Removal vs. Cond.
1.4 mS/cm 2.6 mS/cm 4.7 mS/cm
pH 7.0
42
Comments on the Performances
ü  Performances linked to pH & Cond. ➔ optimizations
ü  ~ 90 % monomer recovery (binding at the beginning)
ü  Up to 95 % aggregate removal possible
ü  > 1 000 g/L-BV loading capacity
➔ 10-20 x higher loading capacity vs. traditional CEX resin
1) Pathogen Removal Filters
3)  Case study:
Combination of CEX Prototype & AEX QyuSpeed D
44
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
45
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Elution buffer
25mM Acetate; pH 3.4
46
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Titration
pH 7.0	
Elution buffer
25mM Acetate; pH 3.4
47
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Aggregate
addition	
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Titration
pH 7.0	
Elution buffer
25mM Acetate; pH 3.4
48
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1041 mg/mL-BV
MAb: 2.6 mg/mL
Flow rate: 6 BV/min
AEX QyuSpeed D
(FT)
Aggregate
addition	
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Titration
pH 7.0	
Elution buffer
25mM Acetate; pH 3.4
49
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1041 mg/mL-BV
MAb: 2.6 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Aggregate
addition	
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Titration
pH 7.0	
Elution buffer
25mM Acetate; pH 3.4
50
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1041 mg/mL-BV
MAb: 2.6 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Loading: 4156 mg/mL-BV
MAb: 2.08 mg/ml
Flow rate: 6 BV/min
Aggregate
addition	
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Titration
pH 7.0	
Elution buffer
25mM Acetate; pH 3.4
51
Combination CEX Prototype & AEX QyuSpeed D
CEX prototype
(FT)
52
Combination CEX Prototype & AEX QyuSpeed D
CEX prototype
(FT)
Monomer	 97.6 %	
Dimer / ≧Trimer	 1.79 % / 0.56 %	
HCP	 349 ppm	
Protein A	 3.6 ppm	
Loading to CEX
53
Combination CEX Prototype & AEX QyuSpeed D
CEX prototype
(FT)
Monomer	 97.6 %	
Dimer / ≧Trimer	 1.79 % / 0.56 %	
HCP	 349 ppm	
Protein A	 3.6 ppm	
Loading to CEX	
Flow Through of CEX	
- 88 %
- 20 %
- 83 %
Monomer	 99.66 %	
Dimer / ≧Trimer	 0.28 % / < DL	
HCP	 279 ppm	
Protein A	 0.6 ppm	
Monomer Recovery: 95 %
54
Combination CEX Prototype & AEX QyuSpeed D
CEX prototype
(FT)
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Monomer	 97.6 %	
Dimer / ≧Trimer	 1.79 % / 0.56 %	
HCP	 349 ppm	
Protein A	 3.6 ppm	
Loading to CEX	
Flow Through of CEX	
- 88 %
- 20 %
- 83 %
Monomer	 99.66 %	
Dimer / ≧Trimer	 0.28 % / < DL	
HCP	 279 ppm	
Protein A	 0.6 ppm	
Monomer Recovery: 95 %
55
Combination CEX Prototype & AEX QyuSpeed D
CEX prototype
(FT)
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Monomer	 97.6 %	
Dimer / ≧Trimer	 1.79 % / 0.56 %	
HCP	 349 ppm	
Protein A	 3.6 ppm	
Loading to CEX	
Flow Through of CEX	
Flow Through of AEX	
- 88 %
- 20 %
- 83 %
Monomer	 99.66 %	
Dimer / ≧Trimer	 0.28 % / < DL	
HCP	 279 ppm	
Protein A	 0.6 ppm	
Monomer Recovery: 95 %	
Monomer	 99.75 %	
Dimer / ≧Trimer	 0.18 % / < DL	
HCP	 < 1 ppm	
Protein A	 0.1 ppm	
Monomer Recovery: 99 %	
- 35 %
- 99 %
- 83 %
1) Pathogen Removal Filters
Conclusion
57
Conclusion
ü  Increasing use of membranes in DSP & Flow Through mode preferred
58
Conclusion
ü  Increasing use of membranes in DSP & Flow Through mode preferred
ü  QyuSpeed D for AEX:
•  Unique grafted-chain & hollow fiber design
•  Excellent binding capacity & salt tolerance for DNA, HCP, Virus removal
•  Very flexible implementation: pre or post Protein A, pre or post CEX
•  Single Use or Reusable
59
Conclusion
ü  Increasing use of membranes in DSP & Flow Through mode preferred
ü  QyuSpeed D for AEX:
•  Unique grafted-chain & hollow fiber design
•  Excellent binding capacity & salt tolerance for DNA, HCP, Virus removal
•  Very flexible implementation: pre or post Protein A, pre or post CEX
•  Single Use or Reusable
ü  QyuSpeed Prototype for CEX:
•  Unique grafted-chain & hollow fiber design
•  Flow Through mode
•  High aggregate removal & monomer recovery @ > 1000 g/L loading
•  Single Use or Reusable
60
Conclusion
ü  Increasing use of membranes in DSP & Flow Through mode preferred
ü  QyuSpeed D for AEX:
•  Unique grafted-chain & hollow fiber design
•  Excellent binding capacity & salt tolerance for DNA, HCP, Virus removal
•  Very flexible implementation: pre or post Protein A, pre or post CEX
•  Single Use or Reusable
ü  QyuSpeed Prototype for CEX:
•  Unique grafted-chain & hollow fiber design
•  Flow Through mode
•  High aggregate removal & monomer recovery @ > 1000 g/L loading
•  Single Use or Reusable
ü  Excellent synergy of both QyuSpeed membranes !
61
Thank you to my Japanese colleagues !
Taniguchi-san
Koguma-san
Shirataki-san
Acknowledgements
62
Thank you to my Japanese colleagues !
Taniguchi-san
Koguma-san
Shirataki-san
And my European Colleagues here today !
Mathithas-san and Konstantin-san
Acknowledgements
63
18th Planova Workshop
ü  22nd & 23rd October 2015 in Athens, Greece
ü  Technical presentations by our customers about their experience
with Planova virus removal filters, BioOptimal TFF, QyuSpeed D
ü  Social activities: discover of the ancient city & special
entertainments in the evenings
ü  Number of attendees: 200
ü  YOU ARE WELCOME TO REGISTER !!
ü  www.ak-bio.com/planova-workshop/workshop-2015-athens/description/
64
どうもありがとう	
Domo	Arigato!		
(thank	you	very	much)
65
1.3 m1.4 m
Industrial References
ü  2 customers using already QyuSpeed D modules 5L
§  Impurities removal by AEX (DNA, HCP),
§  Potential enhancement of Prot. A (very expensive step): better
efficiency, easier regeneration, more cycles.
66
Protein A
UFPlanova
AIEX
CIEX
Centri-
fugation
Tangential MF
Depth
Filtration
or
0.2 Âľm
filtration
AEX with
QyuSpeed D
or much
reduced size
Innovative Implementation: pre Prot. A
Protein A
UFPlanova
AIEX
CIEX
Centri-
fugation
Tangential MF
Depth
Filtration
or
0.2 Âľm
filtration
67
AEX with
QyuSpeed D
or much
reduced size
Other (very) Innovative Implementation:
cell culture harvesting/clarification
Protein A
UFPlanova
AIEX
CIEX
Centri-
fugation
Tangential MF
Depth
Filtration
or
0.2 Âľm
filtration
3 actions in 1 single step:
ü  Cell culture clarification (0.2 µm; TFF mode),
ü  AEX chromatography (DNA, Virus & HCP removal),
ü  “Protection” of Protein A.
68
AEX with
QyuSpeed D
or much
reduced size
Other (very) Innovative Implementation:
cell culture harvesting/clarification
69
Aggregate Removal vs. Cond.
70
Feed solution: MAb (h-IgG1), 5 mg/mL, pI 8.4
Buffer: 15 mM Tris-HCl
pH: 7.0
Loading: ~ 1000 mg/mL-membrane volume (BV)
Flow rate: 6 BV/min
Aggregate Removal vs. Cond.
71
Feed solution: MAb (h-IgG1), 5 mg/mL, pI 8.4
Buffer: 15 mM Tris-HCl
pH: 7.0
Loading: ~ 1000 mg/mL-membrane volume (BV)
Flow rate: 6 BV/min
Conductivity (mS/cm)	 1.4 2.6 4.7
Feed
solution	
Monomer (%) 94.73 95.94 95.49
Dimer (%) 2.25 1.59 2.2
≧ Trimer (%) 3.02 2.47 2.31
Aggregate Removal vs. Cond.
72
Aggregate Removal vs. Cond.
1.4 mS/cm 2.6 mS/cm 4.7 mS/cm
73
Conductivity (mS/cm)	 1.4 2.6 4.7
Monomer recovery (%) 88.87 92.32 89.12
Flow Through	
(reduction %)
Monomer (%) 97.42 99.48 98.59
Dimer (%) 1.34 (49) 0.39 (78) 1.03 (60)
≧ Trimer (%) 1.24 (65) 0.13 (95) 0.38 (86)
Aggregate Removal vs. Cond.
1.4 mS/cm 2.6 mS/cm 4.7 mS/cm
pH 7.0
74
Conductivity (mS/cm)	 1.4 2.6 4.7
Monomer recovery (%) 88.87 92.32 89.12
Flow Through	
(reduction %)
Monomer (%) 97.42 99.48 98.59
Dimer (%) 1.34 (49) 0.39 (78) 1.03 (60)
≧ Trimer (%) 1.24 (65) 0.13 (95) 0.38 (86)
Aggregate Removal vs. Cond.
1.4 mS/cm 2.6 mS/cm 4.7 mS/cm
75
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
76
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Elution buffer
0.1M Citrate; pH 3.4
77
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm	
Elution buffer
0.1M Citrate; pH 3.4
78
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Aggregate
addition	
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm	
Elution buffer
0.1M Citrate; pH 3.4
79
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Aggregate
addition	
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm	
Elution buffer
0.1M Citrate; pH 3.4
80
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1067 mg/mL-MV
MAb: 5.22 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Aggregate
addition	
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm	
Elution buffer
0.1M Citrate; pH 3.4
81
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1067 mg/mL-MV
MAb: 5.22 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Loading: 4713 mg/mL-MV
MAb: 3.80 mg/ml
Flow rate: 6 BV/min
Aggregate
addition	
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm	
Elution buffer
0.1M Citrate; pH 3.4
82
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1067 mg/mL-MV
MAb: 5.22 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Loading: 4713 mg/mL-MV
MAb: 3.80 mg/ml
Flow rate: 6 BV/min
Aggregate
addition	
Clarification
Monomer	 97.77 %	
Dimer /
≧Trimer	
1.32 % / 0.91 %	
HCP	 390 ppm	
Protein A	 0.5 ppm	
Loading to CEX	CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm	
Elution buffer
0.1M Citrate; pH 3.4
83
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1067 mg/mL-MV
MAb: 5.22 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Loading: 4713 mg/mL-MV
MAb: 3.80 mg/ml
Flow rate: 6 BV/min
Aggregate
addition	
Clarification
Monomer	 97.77 %	
Dimer /
≧Trimer	
1.32 % / 0.91 %	
HCP	 390 ppm	
Protein A	 0.5 ppm	
Loading to CEX	
Flow Through of CEX	
- 79 %
- 35 %
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
- 80 %
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm	
Monomer	 99.54 %	
Dimer /
≧Trimer	
0.33 % / 0.14 %	
HCP	 254 ppm	
Protein A	 0.1 ppm	
Monomer Recovery: 87 %	
Elution buffer
0.1M Citrate; pH 3.4
84
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1067 mg/mL-MV
MAb: 5.22 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Loading: 4713 mg/mL-MV
MAb: 3.80 mg/ml
Flow rate: 6 BV/min
Aggregate
addition	
Clarification
Monomer	 97.77 %	
Dimer /
≧Trimer	
1.32 % / 0.91 %	
HCP	 390 ppm	
Protein A	 0.5 ppm	
Loading to CEX	
Flow Through of CEX	
Flow Through of AEX	
- 79 %
- 35 %
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
- 80 %
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm	
Monomer	 99.54 %	
Dimer /
≧Trimer	
0.33 % / 0.14 %	
HCP	 254 ppm	
Protein A	 0.1 ppm	
Monomer Recovery: 87 %	
Monomer	 99.79 %	
Dimer /
≧Trimer	
0.21 % / < DL	
HCP	 6 ppm	
Protein A	 < 0.1 ppm	
Monomer Recovery: 99 %	
- 55 %
- 98 %
Elution buffer
0.1M Citrate; pH 3.4
85
Combination CEX Prototype & AEX QyuSpeed D
0	
0.2	
0.4	
0.6	
0.8	
1	
1.2	
0.00		 200.00		 400.00		 600.00		 800.00		1000.00		
C/C0	
Load	IgG(mg/mL-ad)	
CEX	
Monomer	
Dimer	
≧Trimer	
HCP	
protein	A	
0	
0.2	
0.4	
0.6	
0.8	
1	
1.2	
0	 1000	 2000	 3000	 4000	 5000	
C/C0	
Load	IgG(mg/mL-ad)	
AEX	
Monomer	
Dimer	
≧Trimer	
HCP	
Monomer	 97.77 %	
Dimer /
≧Trimer	
1.32 % / 0.91 %	
HCP	 390 ppm	
Protein A	 0.5 ppm	
Loading to CEX	
Flow Through of CEX	
Flow Through of AEX	
- 79 %
- 35 %
- 80 %
Monomer	 99.54 %	
Dimer /
≧Trimer	
0.33 % / 0.14 %	
HCP	 254 ppm	
Protein A	 0.1 ppm	
Monomer Recovery: 87 %	
Monomer	 99.79 %	
Dimer /
≧Trimer	
0.21 % / < DL	
HCP	 6 ppm	
Protein A	 < 0.1 ppm	
Monomer Recovery: 99 %	
- 55 %
- 98 %
86
Combination CEX Prototype & AEX QyuSpeed D
Monomer	 97.6 %	
Dimer /
≧Trimer	
1.79 % / 0.56 %	
HCP	 349 ppm	
Protein A	 3.6 ppm	
Loading to CEX	
Flow Through of CEX	
Flow Through of AEX	
- 88 %
- 20 %
- 83 %
Monomer	 99.66 %	
Dimer /
≧Trimer	
0.28 % / < DL	
HCP	 279 ppm	
Protein A	 0.6 ppm	
Monomer Recovery: 95 %	
Monomer	 99.75 %	
Dimer /
≧Trimer	
0.18 % / < DL	
HCP	 < 1 ppm	
Protein A	 0.1 ppm	
Monomer Recovery: 99 %	
- 35 %
- 99 %
- 83 %
0	
0.2	
0.4	
0.6	
0.8	
1	
1.2	
0	 200	 400	 600	 800	 1000	
C/C0	
Load	IgG(mg/mL-ad)	
CEX	(NCX)	
Monomer	
Dimer	
>Trimer	
HCP	
Protein	A	
0	
0.2	
0.4	
0.6	
0.8	
1	
1.2	
0	 1000	 2000	 3000	 4000	
C/C0	
Load	IgG(mg/mL-ad)	
AEX	(QSD)	
Monomer	
Dimer	
HCP	
Protein	A
87
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1041 mg/mL-MV
MAb: 2.6 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Loading: 4156 mg/mL-MV
MAb: 2.08 mg/ml
Flow rate: 6 BV/min
Aggregate
addition	
Clarification
Monomer	 97.6 %	
Dimer /
≧Trimer	
1.79 % / 0.56 %	
HCP	 349 ppm	
Protein A	 3.6 ppm	
Loading to CEX	CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
Titration
pH 7.0	
Elution buffer
25mM Acetate; pH 3.4
88
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1041 mg/mL-MV
MAb: 2.6 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Loading: 4156 mg/mL-MV
MAb: 2.08 mg/ml
Flow rate: 6 BV/min
Aggregate
addition	
Clarification
Monomer	 97.6 %	
Dimer /
≧Trimer	
1.79 % / 0.56 %	
HCP	 349 ppm	
Protein A	 3.6 ppm	
Loading to CEX	
Flow Through of CEX	
- 88 %
- 20 %
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
- 83 %
Monomer	 99.66 %	
Dimer /
≧Trimer	
0.28 % / < DL	
HCP	 279 ppm	
Protein A	 0.6 ppm	
Monomer Recovery: 95 %	
Titration
pH 7.0	
Elution buffer
25mM Acetate; pH 3.4
89
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1041 mg/mL-MV
MAb: 2.6 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Loading: 4156 mg/mL-MV
MAb: 2.08 mg/ml
Flow rate: 6 BV/min
Aggregate
addition	
Clarification
Monomer	 97.6 %	
Dimer /
≧Trimer	
1.79 % / 0.56 %	
HCP	 349 ppm	
Protein A	 3.6 ppm	
Loading to CEX	
Flow Through of CEX	
Flow Through of AEX	
- 88 %
- 20 %
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL	
- 83 %
Monomer	 99.66 %	
Dimer /
≧Trimer	
0.28 % / < DL	
HCP	 279 ppm	
Protein A	 0.6 ppm	
Monomer Recovery: 95 %	
Monomer	 99.75 %	
Dimer /
≧Trimer	
0.18 % / < DL	
HCP	 < 1 ppm	
Protein A	 0.1 ppm	
Monomer Recovery: 99 %	
- 35 %
- 99 %
Titration
pH 7.0	
- 83 %
Elution buffer
25mM Acetate; pH 3.4

More Related Content

What's hot

Spectrophotometry & beer's law
Spectrophotometry & beer's lawSpectrophotometry & beer's law
Spectrophotometry & beer's lawDiaa Srahin
 
Cell Line Development: Reducing timelines and increasing titres
Cell Line Development: Reducing timelines and increasing titres Cell Line Development: Reducing timelines and increasing titres
Cell Line Development: Reducing timelines and increasing titres fujifilmdiosynth
 
A hands on guide to ultrafiltration1
A hands on guide to ultrafiltration1A hands on guide to ultrafiltration1
A hands on guide to ultrafiltration1Arash Abed
 
Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)Merck Life Sciences
 
Pellicon 2
Pellicon 2Pellicon 2
Pellicon 2Arash Abed
 
Scale-up of high area filters for microfiltration of biological fluids - Poin...
Scale-up of high area filters for microfiltration of biological fluids - Poin...Scale-up of high area filters for microfiltration of biological fluids - Poin...
Scale-up of high area filters for microfiltration of biological fluids - Poin...MilliporeSigma
 
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...Merck Life Sciences
 
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...Merck Life Sciences
 
Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)MilliporeSigma
 
Process Scale Chromatography
Process Scale ChromatographyProcess Scale Chromatography
Process Scale ChromatographyMerck Life Sciences
 
Wastewater treatment using membrane bioreactors
Wastewater treatment using membrane bioreactorsWastewater treatment using membrane bioreactors
Wastewater treatment using membrane bioreactorsHarishwar R
 
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...Merck Life Sciences
 
Kasur tanneries waste management agency (ktwma)
Kasur tanneries waste management agency (ktwma)Kasur tanneries waste management agency (ktwma)
Kasur tanneries waste management agency (ktwma)Muhammad Imran Nawaz
 
Paper chromatography
Paper chromatographyPaper chromatography
Paper chromatographySadia RaNa
 
Colorimetry B.Sc.III
Colorimetry B.Sc.IIIColorimetry B.Sc.III
Colorimetry B.Sc.IIIswapnil jadhav
 
NĂŁo tenhas medo (retiro de jovens 2013)
NĂŁo tenhas medo (retiro de jovens 2013)NĂŁo tenhas medo (retiro de jovens 2013)
NĂŁo tenhas medo (retiro de jovens 2013)conceicaoborges
 
Real-time PCR
Real-time PCR Real-time PCR
Real-time PCR Iqra Rasheed
 
Wqm 207 –lab analysis and data application
Wqm 207 –lab analysis and data applicationWqm 207 –lab analysis and data application
Wqm 207 –lab analysis and data applicationwqmrrcc
 
Nuclear magnetic resonance by ayush kumawat
Nuclear magnetic resonance by ayush kumawatNuclear magnetic resonance by ayush kumawat
Nuclear magnetic resonance by ayush kumawatAyush Kumawat
 
Ion exchange chromatography
Ion exchange chromatographyIon exchange chromatography
Ion exchange chromatographySakeena Asmi
 

What's hot (20)

Spectrophotometry & beer's law
Spectrophotometry & beer's lawSpectrophotometry & beer's law
Spectrophotometry & beer's law
 
Cell Line Development: Reducing timelines and increasing titres
Cell Line Development: Reducing timelines and increasing titres Cell Line Development: Reducing timelines and increasing titres
Cell Line Development: Reducing timelines and increasing titres
 
A hands on guide to ultrafiltration1
A hands on guide to ultrafiltration1A hands on guide to ultrafiltration1
A hands on guide to ultrafiltration1
 
Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)
 
Pellicon 2
Pellicon 2Pellicon 2
Pellicon 2
 
Scale-up of high area filters for microfiltration of biological fluids - Poin...
Scale-up of high area filters for microfiltration of biological fluids - Poin...Scale-up of high area filters for microfiltration of biological fluids - Poin...
Scale-up of high area filters for microfiltration of biological fluids - Poin...
 
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...
 
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
 
Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)
 
Process Scale Chromatography
Process Scale ChromatographyProcess Scale Chromatography
Process Scale Chromatography
 
Wastewater treatment using membrane bioreactors
Wastewater treatment using membrane bioreactorsWastewater treatment using membrane bioreactors
Wastewater treatment using membrane bioreactors
 
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
 
Kasur tanneries waste management agency (ktwma)
Kasur tanneries waste management agency (ktwma)Kasur tanneries waste management agency (ktwma)
Kasur tanneries waste management agency (ktwma)
 
Paper chromatography
Paper chromatographyPaper chromatography
Paper chromatography
 
Colorimetry B.Sc.III
Colorimetry B.Sc.IIIColorimetry B.Sc.III
Colorimetry B.Sc.III
 
NĂŁo tenhas medo (retiro de jovens 2013)
NĂŁo tenhas medo (retiro de jovens 2013)NĂŁo tenhas medo (retiro de jovens 2013)
NĂŁo tenhas medo (retiro de jovens 2013)
 
Real-time PCR
Real-time PCR Real-time PCR
Real-time PCR
 
Wqm 207 –lab analysis and data application
Wqm 207 –lab analysis and data applicationWqm 207 –lab analysis and data application
Wqm 207 –lab analysis and data application
 
Nuclear magnetic resonance by ayush kumawat
Nuclear magnetic resonance by ayush kumawatNuclear magnetic resonance by ayush kumawat
Nuclear magnetic resonance by ayush kumawat
 
Ion exchange chromatography
Ion exchange chromatographyIon exchange chromatography
Ion exchange chromatography
 

Similar to New Hollow Fiber Membranes for AEX and CEX in Flow-Through Mode

Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...MilliporeSigma
 
BILS 2015 Tosoh Bioscience
BILS 2015 Tosoh BioscienceBILS 2015 Tosoh Bioscience
BILS 2015 Tosoh BioscienceGBX Events
 
Monoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartionMonoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartionshadan87
 
Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...Merck Life Sciences
 
Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...MilliporeSigma
 
TOYOPEARL MX-Trp-650M
TOYOPEARL MX-Trp-650MTOYOPEARL MX-Trp-650M
TOYOPEARL MX-Trp-650MRomain Dabre
 
Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...Kate?ina Svobodov
 
Spps and its applications for bioactive peptides(Rajendra Sonawane)
Spps and its applications for bioactive peptides(Rajendra Sonawane)Spps and its applications for bioactive peptides(Rajendra Sonawane)
Spps and its applications for bioactive peptides(Rajendra Sonawane)Rajendra Sonawane
 
Dicam post-trattamento_case study
Dicam post-trattamento_case studyDicam post-trattamento_case study
Dicam post-trattamento_case studySYNECO
 
Measuring pKas, logP and Solubility by Automated titration
Measuring pKas, logP and Solubility by Automated titrationMeasuring pKas, logP and Solubility by Automated titration
Measuring pKas, logP and Solubility by Automated titrationJon Mole
 
Dr. Elke Prohaska & Regina RĂśmling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina RĂśmling BioInnovation Leader Summit TosohDr. Elke Prohaska & Regina RĂśmling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina RĂśmling BioInnovation Leader Summit TosohGBX Summits
 
BioInnovation Leader Summit Transforming Process Efficiency
 BioInnovation Leader Summit Transforming Process Efficiency BioInnovation Leader Summit Transforming Process Efficiency
BioInnovation Leader Summit Transforming Process EfficiencyGBX Summits
 
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...PerkinElmer, Inc.
 
New Ultra-High Capacity TOYOPEARLÂŽ Protein A Resin
New Ultra-High Capacity TOYOPEARLÂŽ Protein A Resin New Ultra-High Capacity TOYOPEARLÂŽ Protein A Resin
New Ultra-High Capacity TOYOPEARLÂŽ Protein A Resin Tosoh Bioscience GmbH
 
Pds pure blueh2o- pb-tlro4h50t - performance data sheet - 2-27-2015
Pds   pure blueh2o- pb-tlro4h50t - performance data sheet - 2-27-2015Pds   pure blueh2o- pb-tlro4h50t - performance data sheet - 2-27-2015
Pds pure blueh2o- pb-tlro4h50t - performance data sheet - 2-27-2015Cindy Wilton-Maisner
 
GRC_Poster_2015
GRC_Poster_2015GRC_Poster_2015
GRC_Poster_2015David Gunn
 
Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-up	Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-up MilliporeSigma
 
Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-upComplete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-upMerck Life Sciences
 
Chromatography: Trends and Developments in MAb Screening and Characterization
Chromatography: Trends and Developments in MAb Screening and CharacterizationChromatography: Trends and Developments in MAb Screening and Characterization
Chromatography: Trends and Developments in MAb Screening and CharacterizationChromatography & Mass Spectrometry Solutions
 
High-Capacity Capture of a Recombinant Growth Factor Directly From Refold Sol...
High-Capacity Capture of a Recombinant Growth Factor Directly From Refold Sol...High-Capacity Capture of a Recombinant Growth Factor Directly From Refold Sol...
High-Capacity Capture of a Recombinant Growth Factor Directly From Refold Sol...Merck Life Sciences
 

Similar to New Hollow Fiber Membranes for AEX and CEX in Flow-Through Mode (20)

Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
 
BILS 2015 Tosoh Bioscience
BILS 2015 Tosoh BioscienceBILS 2015 Tosoh Bioscience
BILS 2015 Tosoh Bioscience
 
Monoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartionMonoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartion
 
Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...
 
Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...
 
TOYOPEARL MX-Trp-650M
TOYOPEARL MX-Trp-650MTOYOPEARL MX-Trp-650M
TOYOPEARL MX-Trp-650M
 
Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...
 
Spps and its applications for bioactive peptides(Rajendra Sonawane)
Spps and its applications for bioactive peptides(Rajendra Sonawane)Spps and its applications for bioactive peptides(Rajendra Sonawane)
Spps and its applications for bioactive peptides(Rajendra Sonawane)
 
Dicam post-trattamento_case study
Dicam post-trattamento_case studyDicam post-trattamento_case study
Dicam post-trattamento_case study
 
Measuring pKas, logP and Solubility by Automated titration
Measuring pKas, logP and Solubility by Automated titrationMeasuring pKas, logP and Solubility by Automated titration
Measuring pKas, logP and Solubility by Automated titration
 
Dr. Elke Prohaska & Regina RĂśmling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina RĂśmling BioInnovation Leader Summit TosohDr. Elke Prohaska & Regina RĂśmling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina RĂśmling BioInnovation Leader Summit Tosoh
 
BioInnovation Leader Summit Transforming Process Efficiency
 BioInnovation Leader Summit Transforming Process Efficiency BioInnovation Leader Summit Transforming Process Efficiency
BioInnovation Leader Summit Transforming Process Efficiency
 
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
 
New Ultra-High Capacity TOYOPEARLÂŽ Protein A Resin
New Ultra-High Capacity TOYOPEARLÂŽ Protein A Resin New Ultra-High Capacity TOYOPEARLÂŽ Protein A Resin
New Ultra-High Capacity TOYOPEARLÂŽ Protein A Resin
 
Pds pure blueh2o- pb-tlro4h50t - performance data sheet - 2-27-2015
Pds   pure blueh2o- pb-tlro4h50t - performance data sheet - 2-27-2015Pds   pure blueh2o- pb-tlro4h50t - performance data sheet - 2-27-2015
Pds pure blueh2o- pb-tlro4h50t - performance data sheet - 2-27-2015
 
GRC_Poster_2015
GRC_Poster_2015GRC_Poster_2015
GRC_Poster_2015
 
Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-up	Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-up
 
Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-upComplete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-up
 
Chromatography: Trends and Developments in MAb Screening and Characterization
Chromatography: Trends and Developments in MAb Screening and CharacterizationChromatography: Trends and Developments in MAb Screening and Characterization
Chromatography: Trends and Developments in MAb Screening and Characterization
 
High-Capacity Capture of a Recombinant Growth Factor Directly From Refold Sol...
High-Capacity Capture of a Recombinant Growth Factor Directly From Refold Sol...High-Capacity Capture of a Recombinant Growth Factor Directly From Refold Sol...
High-Capacity Capture of a Recombinant Growth Factor Directly From Refold Sol...
 

More from GBX Events

BILS 2015 University of Birmingham Roy Jefferis
BILS 2015 University of Birmingham Roy JefferisBILS 2015 University of Birmingham Roy Jefferis
BILS 2015 University of Birmingham Roy JefferisGBX Events
 
BILS 2015 Umetrics Stefan Raennar
BILS 2015 Umetrics Stefan RaennarBILS 2015 Umetrics Stefan Raennar
BILS 2015 Umetrics Stefan RaennarGBX Events
 
BILS 2015 Bayer Pharma AG Markus Eser
BILS 2015 Bayer Pharma AG Markus EserBILS 2015 Bayer Pharma AG Markus Eser
BILS 2015 Bayer Pharma AG Markus EserGBX Events
 
BILS 2015 Christoph Herwig
BILS 2015 Christoph HerwigBILS 2015 Christoph Herwig
BILS 2015 Christoph HerwigGBX Events
 
BILS 2015 Genethon M. Hebben
BILS 2015 Genethon M. HebbenBILS 2015 Genethon M. Hebben
BILS 2015 Genethon M. HebbenGBX Events
 
BILS 2015 OctoPlus and Dr. Reddy's
BILS 2015 OctoPlus and Dr. Reddy'sBILS 2015 OctoPlus and Dr. Reddy's
BILS 2015 OctoPlus and Dr. Reddy'sGBX Events
 
BILS 2015, F. Wolpers Hamilton Bonaduz AG
BILS 2015, F. Wolpers Hamilton Bonaduz AGBILS 2015, F. Wolpers Hamilton Bonaduz AG
BILS 2015, F. Wolpers Hamilton Bonaduz AGGBX Events
 
Ingenza BILS 2016
Ingenza BILS 2016Ingenza BILS 2016
Ingenza BILS 2016GBX Events
 
Novartis BILS 2016
Novartis BILS 2016Novartis BILS 2016
Novartis BILS 2016GBX Events
 
Newcastle BILS 2016
Newcastle BILS 2016Newcastle BILS 2016
Newcastle BILS 2016GBX Events
 
Filtrox BILS 2016
Filtrox BILS 2016Filtrox BILS 2016
Filtrox BILS 2016GBX Events
 
Soligenix BILS 2016
Soligenix BILS 2016Soligenix BILS 2016
Soligenix BILS 2016GBX Events
 
BOKU BILS 2016
BOKU BILS 2016BOKU BILS 2016
BOKU BILS 2016GBX Events
 
Boedeker Bayer BILS 2016
Boedeker Bayer BILS 2016Boedeker Bayer BILS 2016
Boedeker Bayer BILS 2016GBX Events
 
Tosoh BILS 2016
Tosoh BILS 2016Tosoh BILS 2016
Tosoh BILS 2016GBX Events
 
Contemporary Clinical Trials 2015
Contemporary Clinical Trials 2015Contemporary Clinical Trials 2015
Contemporary Clinical Trials 2015GBX Events
 
DEC 3 2015 Mats Sundgren
DEC 3 2015 Mats SundgrenDEC 3 2015 Mats Sundgren
DEC 3 2015 Mats SundgrenGBX Events
 
Press release
Press releasePress release
Press releaseGBX Events
 
PIMS Feb. 2016 DHL Resilience360
PIMS Feb. 2016 DHL Resilience360PIMS Feb. 2016 DHL Resilience360
PIMS Feb. 2016 DHL Resilience360GBX Events
 
PIMS Feb. 2016 Packaging Innovation
PIMS Feb. 2016 Packaging Innovation PIMS Feb. 2016 Packaging Innovation
PIMS Feb. 2016 Packaging Innovation GBX Events
 

More from GBX Events (20)

BILS 2015 University of Birmingham Roy Jefferis
BILS 2015 University of Birmingham Roy JefferisBILS 2015 University of Birmingham Roy Jefferis
BILS 2015 University of Birmingham Roy Jefferis
 
BILS 2015 Umetrics Stefan Raennar
BILS 2015 Umetrics Stefan RaennarBILS 2015 Umetrics Stefan Raennar
BILS 2015 Umetrics Stefan Raennar
 
BILS 2015 Bayer Pharma AG Markus Eser
BILS 2015 Bayer Pharma AG Markus EserBILS 2015 Bayer Pharma AG Markus Eser
BILS 2015 Bayer Pharma AG Markus Eser
 
BILS 2015 Christoph Herwig
BILS 2015 Christoph HerwigBILS 2015 Christoph Herwig
BILS 2015 Christoph Herwig
 
BILS 2015 Genethon M. Hebben
BILS 2015 Genethon M. HebbenBILS 2015 Genethon M. Hebben
BILS 2015 Genethon M. Hebben
 
BILS 2015 OctoPlus and Dr. Reddy's
BILS 2015 OctoPlus and Dr. Reddy'sBILS 2015 OctoPlus and Dr. Reddy's
BILS 2015 OctoPlus and Dr. Reddy's
 
BILS 2015, F. Wolpers Hamilton Bonaduz AG
BILS 2015, F. Wolpers Hamilton Bonaduz AGBILS 2015, F. Wolpers Hamilton Bonaduz AG
BILS 2015, F. Wolpers Hamilton Bonaduz AG
 
Ingenza BILS 2016
Ingenza BILS 2016Ingenza BILS 2016
Ingenza BILS 2016
 
Novartis BILS 2016
Novartis BILS 2016Novartis BILS 2016
Novartis BILS 2016
 
Newcastle BILS 2016
Newcastle BILS 2016Newcastle BILS 2016
Newcastle BILS 2016
 
Filtrox BILS 2016
Filtrox BILS 2016Filtrox BILS 2016
Filtrox BILS 2016
 
Soligenix BILS 2016
Soligenix BILS 2016Soligenix BILS 2016
Soligenix BILS 2016
 
BOKU BILS 2016
BOKU BILS 2016BOKU BILS 2016
BOKU BILS 2016
 
Boedeker Bayer BILS 2016
Boedeker Bayer BILS 2016Boedeker Bayer BILS 2016
Boedeker Bayer BILS 2016
 
Tosoh BILS 2016
Tosoh BILS 2016Tosoh BILS 2016
Tosoh BILS 2016
 
Contemporary Clinical Trials 2015
Contemporary Clinical Trials 2015Contemporary Clinical Trials 2015
Contemporary Clinical Trials 2015
 
DEC 3 2015 Mats Sundgren
DEC 3 2015 Mats SundgrenDEC 3 2015 Mats Sundgren
DEC 3 2015 Mats Sundgren
 
Press release
Press releasePress release
Press release
 
PIMS Feb. 2016 DHL Resilience360
PIMS Feb. 2016 DHL Resilience360PIMS Feb. 2016 DHL Resilience360
PIMS Feb. 2016 DHL Resilience360
 
PIMS Feb. 2016 Packaging Innovation
PIMS Feb. 2016 Packaging Innovation PIMS Feb. 2016 Packaging Innovation
PIMS Feb. 2016 Packaging Innovation
 

Recently uploaded

Manassas R - Parkside Middle School 🌎🏫
Manassas R - Parkside Middle School 🌎🏫Manassas R - Parkside Middle School 🌎🏫
Manassas R - Parkside Middle School 🌎🏫qfactory1
 
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfBehavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfSELF-EXPLANATORY
 
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptxLIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptxmalonesandreagweneth
 
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptxTHE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptxNandakishor Bhaurao Deshmukh
 
Temporomandibular joint Muscles of Mastication
Temporomandibular joint Muscles of MasticationTemporomandibular joint Muscles of Mastication
Temporomandibular joint Muscles of Masticationvidulajaib
 
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfSwapnil Therkar
 
Microphone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptxMicrophone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptxpriyankatabhane
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxkessiyaTpeter
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSarthak Sekhar Mondal
 
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...lizamodels9
 
Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |aasikanpl
 
Harmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms PresentationHarmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms Presentationtahreemzahra82
 
Gas_Laws_powerpoint_notes.ppt for grade 10
Gas_Laws_powerpoint_notes.ppt for grade 10Gas_Laws_powerpoint_notes.ppt for grade 10
Gas_Laws_powerpoint_notes.ppt for grade 10ROLANARIBATO3
 
Twin's paradox experiment is a meassurement of the extra dimensions.pptx
Twin's paradox experiment is a meassurement of the extra dimensions.pptxTwin's paradox experiment is a meassurement of the extra dimensions.pptx
Twin's paradox experiment is a meassurement of the extra dimensions.pptxEran Akiva Sinbar
 
insect anatomy and insect body wall and their physiology
insect anatomy and insect body wall and their  physiologyinsect anatomy and insect body wall and their  physiology
insect anatomy and insect body wall and their physiologyDrAnita Sharma
 
Solution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsSolution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsHajira Mahmood
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxSwapnil Therkar
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 

Recently uploaded (20)

Manassas R - Parkside Middle School 🌎🏫
Manassas R - Parkside Middle School 🌎🏫Manassas R - Parkside Middle School 🌎🏫
Manassas R - Parkside Middle School 🌎🏫
 
Hot Sexy call girls in Moti Nagar,🔝 9953056974 🔝 escort Service
Hot Sexy call girls in  Moti Nagar,🔝 9953056974 🔝 escort ServiceHot Sexy call girls in  Moti Nagar,🔝 9953056974 🔝 escort Service
Hot Sexy call girls in Moti Nagar,🔝 9953056974 🔝 escort Service
 
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfBehavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
 
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptxLIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
 
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptxTHE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
 
Temporomandibular joint Muscles of Mastication
Temporomandibular joint Muscles of MasticationTemporomandibular joint Muscles of Mastication
Temporomandibular joint Muscles of Mastication
 
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
 
Microphone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptxMicrophone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptx
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
 
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
 
Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |
 
Harmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms PresentationHarmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms Presentation
 
Gas_Laws_powerpoint_notes.ppt for grade 10
Gas_Laws_powerpoint_notes.ppt for grade 10Gas_Laws_powerpoint_notes.ppt for grade 10
Gas_Laws_powerpoint_notes.ppt for grade 10
 
Twin's paradox experiment is a meassurement of the extra dimensions.pptx
Twin's paradox experiment is a meassurement of the extra dimensions.pptxTwin's paradox experiment is a meassurement of the extra dimensions.pptx
Twin's paradox experiment is a meassurement of the extra dimensions.pptx
 
insect anatomy and insect body wall and their physiology
insect anatomy and insect body wall and their  physiologyinsect anatomy and insect body wall and their  physiology
insect anatomy and insect body wall and their physiology
 
Solution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsSolution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutions
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 

New Hollow Fiber Membranes for AEX and CEX in Flow-Through Mode

  • 1. New Hollow Fiber Membranes for AEX and CEX in Flow-Through Mode Bixente MARTIRENE, MSc Senior Product Manager Asahi Kasei Bioprocess Europe b.martirene@akbio.eu 8th Annual European BioInnovation Leaders Summit 10th - 11th February 2015 Radisson Blu Edwardian Hotel, London www.ak-bio.com
  • 2. 1) Pathogen Removal Filters Content Introduction 1)  Hollow Fiber Membrane for AEX: QyuSpeed D 2)  Hollow Fiber Membrane Prototype for CEX 3)  Case study: Combination of CEX Prototype & AEX QyuSpeed D Conclusion
  • 3. Foundation: 1931; HQ: Tokyo; Employees: 25 000; Turnover: 16 B$ Asahi Kasei Group 3
  • 5. PlanovaTM Virus removal filters QyuSpeedTM D AEX adsorber BioOptimalTM MF-SL TFF microfilter Asahi Kasei Bioprocess 5
  • 6. PlanovaTM Virus removal filters QyuSpeedTM D AEX adsorber BioOptimalTM MF-SL TFF microfilter Systems & Equipment Asahi Kasei Bioprocess 6
  • 7. PlanovaTM Virus removal filters QyuSpeedTM D AEX adsorber BioOptimalTM MF-SL TFF microfilter Systems & Equipment CellufineTM Cellulose Beads Chromatography media (made by JMC Corporation) Asahi Kasei Bioprocess 7
  • 8. 1) Pathogen Removal Filters Introduction
  • 9. 9 Why Membrane vs. Resin ? ü  Mass transfer: “fast” convection vs. “slow” diffusion ü  5-13 BV*/min vs. 0.5-2 BV/min, low pressure drop ü  10-20 x higher loading capacity ➔ smaller BV required ü  Easy setup & operation ≈ Dead-End Filter Introduction * : Bed Volume = Column Volume = Membrane Volume
  • 10. 10 Introduction Feedback from our customers: ü  Flow-Through mode preferred for ease of use ü  AEX adsorbers more & more implemented in DSP ü  CEX mainly performed with classical resins
  • 11. 11 Introduction Asahi Kasei BioProcess: ü  QyuSpeed D launched in 2011 for AEX ➔ Success ü  New Hollow Fiber Membrane for CEX in FT mode ???
  • 12. 1) Pathogen Removal Filters 1)  Hollow Fiber Membrane for AEX: QyuSpeed D
  • 13. 13 QyuSpeed D AEX Adsorber Inlet Outlet QyuSpeed D Module
  • 14. 14 QyuSpeed D AEX Adsorber Inlet Outlet Hollow fiberQyuSpeed D Module Protein solution with biomolecules - Protein solution biomolecules - free §  Dead-End filtration §  Removal of HCP, DNA, Virus
  • 15. 15 QyuSpeed D AEX Adsorber Inside the pore Grafted chain with DEA ligands Biomolecules - Micropore 0.2-0.3 Âľm >
  • 16. 16 QyuSpeed D AEX Adsorber Inside the pore Grafted chain with DEA ligands Biomolecules - Micropore 0.2-0.3 Âľm H2C C-C-O-CH2CHCH2H3C- = O HO NH(CH2CH3)2 + () H2C C-C-O-CH2CHCH2H3C- = O HO () NH(CH2CH3)2 + Poly glycidyl methacrylate Grafted chain DEA > >
  • 17. 17 QyuSpeed D AEX Adsorber ü  Multipoint adsorption ü  High ligand density Inside the pore Grafted chain with DEA ligands Biomolecules - Micropore 0.2-0.3 Âľm H2C C-C-O-CH2CHCH2H3C- = O HO NH(CH2CH3)2 + () H2C C-C-O-CH2CHCH2H3C- = O HO () NH(CH2CH3)2 + Poly glycidyl methacrylate Grafted chain DEA ➔ high DBC & Salt tolerance > >
  • 18. 18 Product Line-Up Membrane (Bed) Volume 0.6 mL 150 mL 550 mL 5 L Maximum Flow Rate 8 mL/min 2 L/min 8 L/min 60 L/min 0.6 mL 150 mL 550 mL 5 L 1172 mm 315 mm
  • 20. 1)  Post Protein A, in place of traditional AEX resin column 2)  Post CEX w/o any prior dilution or buffer change: salt tolerant Protein A UFPlanova CIEX Centri- fugation Tangential MF Depth Filtration or 0.2 Âľm filtration 20 AEX with QyuSpeed D Classical Implementations of QyuSpeed D
  • 21. 10% BSA DBC > 40 g/L-BV 10% DNA DBC @ 15 mS/cm < 30 g/L-BV HCP reduction 25 – 99 % removal (depending on pI of HCP) Parvovirus LRV > 4 Log MAb Loading capacity Post Protein A (in standard flow through mode) > 2000 g/L-BV (depending on quantities of impurities) Number of regenerations > 10 (tested up to 100 x with BSA) 21 Performances
  • 22. 22 Advantages vs. other AEX Adsorbers ü  Same membrane for low or high conductivity solutions ü  “flexible” implementation: pre or post Prot. A, pre or post CEX ü  Single-use or Reusable (1M NaCl; 1N NaOH)
  • 23. 23 2)  Hollow Fiber Membrane Prototype for CEX
  • 24. 24 2)  Hollow Fiber Membrane Prototype for CEX ➔ CEX in FT mode
  • 25. 25 New QyuSpeed Prototype for CEX Inlet Lab module Outlet
  • 26. 26 New QyuSpeed Prototype for CEX Inlet §  Flow Through mode = Dead- End filtration §  Removal of Aggregates, Prot. A, HCP Outlet Lab module
  • 27. 27 New QyuSpeed Prototype for CEX Inlet Hollow fiber Protein solution with aggregates Protein solution aggregate free Outlet Lab module §  Flow Through mode = Dead- End filtration §  Removal of Aggregates, Prot. A, HCP
  • 28. 28 Inside the pore Grafted chain with 3 different ligands Aggregate Micropore 0.2-0.3 Âľm > New QyuSpeed Prototype for CEX
  • 29. 29 Inside the pore Grafted chain with 3 different ligands Aggregate Micropore 0.2-0.3 Âľm Grafted chain > > New QyuSpeed Prototype for CEX -R1 -R2 -R3 R1, R2 & R3 are side chains with different ligands & interactions
  • 31. 31 Aggregate Removal vs. pH Feed solution: MAb (h-IgG1), 5 mg/mL, pI 8.4 Buffer: 15 mM Tris-HCl Conductivity: 1.4 mS/cm Loading: ~ 1 000 g/L-membrane volume (BV) Flow rate: 6 BV/min Aggregate content: ~ 5 %
  • 32. 32 Aggregate Removal vs. pH Feed solution: MAb (h-IgG1), 5 mg/mL, pI 8.4 Buffer: 15 mM Tris-HCl Conductivity: 1.4 mS/cm Loading: ~ 1 000 g/L-membrane volume (BV) Flow rate: 6 BV/min Aggregate content: ~ 5 % pH 7.0 pH 7.5 pH 8.0 Feed solution Monomer (%) 94.73 94.51 93.54 Dimer (%) 2.25 2.76 3.58 ≧ Trimer (%) 3.02 2.73 2.88
  • 33. 33 Aggregate Removal vs. pH pH 7.0 pH 7.5 pH 8.0
  • 34. 34 Aggregate Removal vs. pH pH 7.0 pH 7.5 pH 8.0 pH 7.0 pH 7.5 pH 8.0 Monomer recovery (%) 88.87 92.2 93.07
  • 35. 35 Aggregate Removal vs. pH pH 7.0 pH 7.5 pH 8.0 pH 7.0 pH 7.5 pH 8.0 Monomer recovery (%) 88.87 92.2 93.07 Flow Through (reduction %) Monomer (%) 97.42 Dimer (%) 1.34 (49) ≧ Trimer (%) 1.24 (65)
  • 36. 36 Aggregate Removal vs. pH pH 7.0 pH 7.5 pH 8.0 pH 7.0 pH 7.5 pH 8.0 Monomer recovery (%) 88.87 92.2 93.07 Flow Through (reduction %) Monomer (%) 97.42 98.65 Dimer (%) 1.34 (49) 1.10 (65) ≧ Trimer (%) 1.24 (65) 0.25 (92)
  • 37. 37 Aggregate Removal vs. pH pH 7.0 pH 7.5 pH 8.0 pH 7.0 pH 7.5 pH 8.0 Monomer recovery (%) 88.87 92.2 93.07 Flow Through (reduction %) Monomer (%) 97.42 98.65 97.98 Dimer (%) 1.34 (49) 1.10 (65) 1.74 (57) ≧ Trimer (%) 1.24 (65) 0.25 (92) 0.28 (91)
  • 38. 38 Aggregate Removal vs. pH pH 7.0 pH 7.5 pH 8.0 pH 7.0 pH 7.5 pH 8.0 Monomer recovery (%) 88.87 92.2 93.07 Flow Through (reduction %) Monomer (%) 97.42 98.65 97.98 Dimer (%) 1.34 (49) 1.10 (65) 1.74 (57) ≧ Trimer (%) 1.24 (65) 0.25 (92) 0.28 (91)
  • 40. 40 Aggregate Removal vs. Cond. 1.4 mS/cm 2.6 mS/cm 4.7 mS/cm
  • 41. 41 Conductivity (mS/cm) 1.4 2.6 4.7 Monomer recovery (%) 88.87 92.32 89.12 Flow Through (reduction %) Monomer (%) 97.42 99.48 98.59 Dimer (%) 1.34 (49) 0.39 (78) 1.03 (60) ≧ Trimer (%) 1.24 (65) 0.13 (95) 0.38 (86) Aggregate Removal vs. Cond. 1.4 mS/cm 2.6 mS/cm 4.7 mS/cm pH 7.0
  • 42. 42 Comments on the Performances ü  Performances linked to pH & Cond. ➔ optimizations ü  ~ 90 % monomer recovery (binding at the beginning) ü  Up to 95 % aggregate removal possible ü  > 1 000 g/L-BV loading capacity ➔ 10-20 x higher loading capacity vs. traditional CEX resin
  • 43. 1) Pathogen Removal Filters 3)  Case study: Combination of CEX Prototype & AEX QyuSpeed D
  • 44. 44 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) AEX QyuSpeed D (FT) Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
  • 45. 45 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) AEX QyuSpeed D (FT) Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Elution buffer 25mM Acetate; pH 3.4
  • 46. 46 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) AEX QyuSpeed D (FT) Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Titration pH 7.0 Elution buffer 25mM Acetate; pH 3.4
  • 47. 47 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) AEX QyuSpeed D (FT) Aggregate addition Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Titration pH 7.0 Elution buffer 25mM Acetate; pH 3.4
  • 48. 48 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) Loading: 1041 mg/mL-BV MAb: 2.6 mg/mL Flow rate: 6 BV/min AEX QyuSpeed D (FT) Aggregate addition Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Titration pH 7.0 Elution buffer 25mM Acetate; pH 3.4
  • 49. 49 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) Loading: 1041 mg/mL-BV MAb: 2.6 mg/mL Flow rate: 6 BV/min Titration pH 7.8 AEX QyuSpeed D (FT) Aggregate addition Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Titration pH 7.0 Elution buffer 25mM Acetate; pH 3.4
  • 50. 50 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) Loading: 1041 mg/mL-BV MAb: 2.6 mg/mL Flow rate: 6 BV/min Titration pH 7.8 AEX QyuSpeed D (FT) Loading: 4156 mg/mL-BV MAb: 2.08 mg/ml Flow rate: 6 BV/min Aggregate addition Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Titration pH 7.0 Elution buffer 25mM Acetate; pH 3.4
  • 51. 51 Combination CEX Prototype & AEX QyuSpeed D CEX prototype (FT)
  • 52. 52 Combination CEX Prototype & AEX QyuSpeed D CEX prototype (FT) Monomer 97.6 % Dimer / ≧Trimer 1.79 % / 0.56 % HCP 349 ppm Protein A 3.6 ppm Loading to CEX
  • 53. 53 Combination CEX Prototype & AEX QyuSpeed D CEX prototype (FT) Monomer 97.6 % Dimer / ≧Trimer 1.79 % / 0.56 % HCP 349 ppm Protein A 3.6 ppm Loading to CEX Flow Through of CEX - 88 % - 20 % - 83 % Monomer 99.66 % Dimer / ≧Trimer 0.28 % / < DL HCP 279 ppm Protein A 0.6 ppm Monomer Recovery: 95 %
  • 54. 54 Combination CEX Prototype & AEX QyuSpeed D CEX prototype (FT) Titration pH 7.8 AEX QyuSpeed D (FT) Monomer 97.6 % Dimer / ≧Trimer 1.79 % / 0.56 % HCP 349 ppm Protein A 3.6 ppm Loading to CEX Flow Through of CEX - 88 % - 20 % - 83 % Monomer 99.66 % Dimer / ≧Trimer 0.28 % / < DL HCP 279 ppm Protein A 0.6 ppm Monomer Recovery: 95 %
  • 55. 55 Combination CEX Prototype & AEX QyuSpeed D CEX prototype (FT) Titration pH 7.8 AEX QyuSpeed D (FT) Monomer 97.6 % Dimer / ≧Trimer 1.79 % / 0.56 % HCP 349 ppm Protein A 3.6 ppm Loading to CEX Flow Through of CEX Flow Through of AEX - 88 % - 20 % - 83 % Monomer 99.66 % Dimer / ≧Trimer 0.28 % / < DL HCP 279 ppm Protein A 0.6 ppm Monomer Recovery: 95 % Monomer 99.75 % Dimer / ≧Trimer 0.18 % / < DL HCP < 1 ppm Protein A 0.1 ppm Monomer Recovery: 99 % - 35 % - 99 % - 83 %
  • 56. 1) Pathogen Removal Filters Conclusion
  • 57. 57 Conclusion ü  Increasing use of membranes in DSP & Flow Through mode preferred
  • 58. 58 Conclusion ü  Increasing use of membranes in DSP & Flow Through mode preferred ü  QyuSpeed D for AEX: •  Unique grafted-chain & hollow fiber design •  Excellent binding capacity & salt tolerance for DNA, HCP, Virus removal •  Very flexible implementation: pre or post Protein A, pre or post CEX •  Single Use or Reusable
  • 59. 59 Conclusion ü  Increasing use of membranes in DSP & Flow Through mode preferred ü  QyuSpeed D for AEX: •  Unique grafted-chain & hollow fiber design •  Excellent binding capacity & salt tolerance for DNA, HCP, Virus removal •  Very flexible implementation: pre or post Protein A, pre or post CEX •  Single Use or Reusable ü  QyuSpeed Prototype for CEX: •  Unique grafted-chain & hollow fiber design •  Flow Through mode •  High aggregate removal & monomer recovery @ > 1000 g/L loading •  Single Use or Reusable
  • 60. 60 Conclusion ü  Increasing use of membranes in DSP & Flow Through mode preferred ü  QyuSpeed D for AEX: •  Unique grafted-chain & hollow fiber design •  Excellent binding capacity & salt tolerance for DNA, HCP, Virus removal •  Very flexible implementation: pre or post Protein A, pre or post CEX •  Single Use or Reusable ü  QyuSpeed Prototype for CEX: •  Unique grafted-chain & hollow fiber design •  Flow Through mode •  High aggregate removal & monomer recovery @ > 1000 g/L loading •  Single Use or Reusable ü  Excellent synergy of both QyuSpeed membranes !
  • 61. 61 Thank you to my Japanese colleagues ! Taniguchi-san Koguma-san Shirataki-san Acknowledgements
  • 62. 62 Thank you to my Japanese colleagues ! Taniguchi-san Koguma-san Shirataki-san And my European Colleagues here today ! Mathithas-san and Konstantin-san Acknowledgements
  • 63. 63 18th Planova Workshop ü  22nd & 23rd October 2015 in Athens, Greece ü  Technical presentations by our customers about their experience with Planova virus removal filters, BioOptimal TFF, QyuSpeed D ü  Social activities: discover of the ancient city & special entertainments in the evenings ü  Number of attendees: 200 ü  YOU ARE WELCOME TO REGISTER !! ü  www.ak-bio.com/planova-workshop/workshop-2015-athens/description/
  • 65. 65 1.3 m1.4 m Industrial References ü  2 customers using already QyuSpeed D modules 5L
  • 66. §  Impurities removal by AEX (DNA, HCP), §  Potential enhancement of Prot. A (very expensive step): better efficiency, easier regeneration, more cycles. 66 Protein A UFPlanova AIEX CIEX Centri- fugation Tangential MF Depth Filtration or 0.2 Âľm filtration AEX with QyuSpeed D or much reduced size Innovative Implementation: pre Prot. A
  • 67. Protein A UFPlanova AIEX CIEX Centri- fugation Tangential MF Depth Filtration or 0.2 Âľm filtration 67 AEX with QyuSpeed D or much reduced size Other (very) Innovative Implementation: cell culture harvesting/clarification
  • 68. Protein A UFPlanova AIEX CIEX Centri- fugation Tangential MF Depth Filtration or 0.2 Âľm filtration 3 actions in 1 single step: ü  Cell culture clarification (0.2 Âľm; TFF mode), ü  AEX chromatography (DNA, Virus & HCP removal), ü  “Protection” of Protein A. 68 AEX with QyuSpeed D or much reduced size Other (very) Innovative Implementation: cell culture harvesting/clarification
  • 70. 70 Feed solution: MAb (h-IgG1), 5 mg/mL, pI 8.4 Buffer: 15 mM Tris-HCl pH: 7.0 Loading: ~ 1000 mg/mL-membrane volume (BV) Flow rate: 6 BV/min Aggregate Removal vs. Cond.
  • 71. 71 Feed solution: MAb (h-IgG1), 5 mg/mL, pI 8.4 Buffer: 15 mM Tris-HCl pH: 7.0 Loading: ~ 1000 mg/mL-membrane volume (BV) Flow rate: 6 BV/min Conductivity (mS/cm) 1.4 2.6 4.7 Feed solution Monomer (%) 94.73 95.94 95.49 Dimer (%) 2.25 1.59 2.2 ≧ Trimer (%) 3.02 2.47 2.31 Aggregate Removal vs. Cond.
  • 72. 72 Aggregate Removal vs. Cond. 1.4 mS/cm 2.6 mS/cm 4.7 mS/cm
  • 73. 73 Conductivity (mS/cm) 1.4 2.6 4.7 Monomer recovery (%) 88.87 92.32 89.12 Flow Through (reduction %) Monomer (%) 97.42 99.48 98.59 Dimer (%) 1.34 (49) 0.39 (78) 1.03 (60) ≧ Trimer (%) 1.24 (65) 0.13 (95) 0.38 (86) Aggregate Removal vs. Cond. 1.4 mS/cm 2.6 mS/cm 4.7 mS/cm pH 7.0
  • 74. 74 Conductivity (mS/cm) 1.4 2.6 4.7 Monomer recovery (%) 88.87 92.32 89.12 Flow Through (reduction %) Monomer (%) 97.42 99.48 98.59 Dimer (%) 1.34 (49) 0.39 (78) 1.03 (60) ≧ Trimer (%) 1.24 (65) 0.13 (95) 0.38 (86) Aggregate Removal vs. Cond. 1.4 mS/cm 2.6 mS/cm 4.7 mS/cm
  • 75. 75 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) AEX QyuSpeed D (FT) Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
  • 76. 76 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) AEX QyuSpeed D (FT) Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Elution buffer 0.1M Citrate; pH 3.4
  • 77. 77 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) AEX QyuSpeed D (FT) Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Buffer change 15 mM Tris-HCl pH 7.0; Cond. 1.4 mS/cm Elution buffer 0.1M Citrate; pH 3.4
  • 78. 78 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) AEX QyuSpeed D (FT) Aggregate addition Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Buffer change 15 mM Tris-HCl pH 7.0; Cond. 1.4 mS/cm Elution buffer 0.1M Citrate; pH 3.4
  • 79. 79 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) Titration pH 7.8 AEX QyuSpeed D (FT) Aggregate addition Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Buffer change 15 mM Tris-HCl pH 7.0; Cond. 1.4 mS/cm Elution buffer 0.1M Citrate; pH 3.4
  • 80. 80 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) Loading: 1067 mg/mL-MV MAb: 5.22 mg/mL Flow rate: 6 BV/min Titration pH 7.8 AEX QyuSpeed D (FT) Aggregate addition Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Buffer change 15 mM Tris-HCl pH 7.0; Cond. 1.4 mS/cm Elution buffer 0.1M Citrate; pH 3.4
  • 81. 81 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) Loading: 1067 mg/mL-MV MAb: 5.22 mg/mL Flow rate: 6 BV/min Titration pH 7.8 AEX QyuSpeed D (FT) Loading: 4713 mg/mL-MV MAb: 3.80 mg/ml Flow rate: 6 BV/min Aggregate addition Clarification CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Buffer change 15 mM Tris-HCl pH 7.0; Cond. 1.4 mS/cm Elution buffer 0.1M Citrate; pH 3.4
  • 82. 82 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) Loading: 1067 mg/mL-MV MAb: 5.22 mg/mL Flow rate: 6 BV/min Titration pH 7.8 AEX QyuSpeed D (FT) Loading: 4713 mg/mL-MV MAb: 3.80 mg/ml Flow rate: 6 BV/min Aggregate addition Clarification Monomer 97.77 % Dimer / ≧Trimer 1.32 % / 0.91 % HCP 390 ppm Protein A 0.5 ppm Loading to CEX CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Buffer change 15 mM Tris-HCl pH 7.0; Cond. 1.4 mS/cm Elution buffer 0.1M Citrate; pH 3.4
  • 83. 83 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) Loading: 1067 mg/mL-MV MAb: 5.22 mg/mL Flow rate: 6 BV/min Titration pH 7.8 AEX QyuSpeed D (FT) Loading: 4713 mg/mL-MV MAb: 3.80 mg/ml Flow rate: 6 BV/min Aggregate addition Clarification Monomer 97.77 % Dimer / ≧Trimer 1.32 % / 0.91 % HCP 390 ppm Protein A 0.5 ppm Loading to CEX Flow Through of CEX - 79 % - 35 % CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL - 80 % Buffer change 15 mM Tris-HCl pH 7.0; Cond. 1.4 mS/cm Monomer 99.54 % Dimer / ≧Trimer 0.33 % / 0.14 % HCP 254 ppm Protein A 0.1 ppm Monomer Recovery: 87 % Elution buffer 0.1M Citrate; pH 3.4
  • 84. 84 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) Loading: 1067 mg/mL-MV MAb: 5.22 mg/mL Flow rate: 6 BV/min Titration pH 7.8 AEX QyuSpeed D (FT) Loading: 4713 mg/mL-MV MAb: 3.80 mg/ml Flow rate: 6 BV/min Aggregate addition Clarification Monomer 97.77 % Dimer / ≧Trimer 1.32 % / 0.91 % HCP 390 ppm Protein A 0.5 ppm Loading to CEX Flow Through of CEX Flow Through of AEX - 79 % - 35 % CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL - 80 % Buffer change 15 mM Tris-HCl pH 7.0; Cond. 1.4 mS/cm Monomer 99.54 % Dimer / ≧Trimer 0.33 % / 0.14 % HCP 254 ppm Protein A 0.1 ppm Monomer Recovery: 87 % Monomer 99.79 % Dimer / ≧Trimer 0.21 % / < DL HCP 6 ppm Protein A < 0.1 ppm Monomer Recovery: 99 % - 55 % - 98 % Elution buffer 0.1M Citrate; pH 3.4
  • 85. 85 Combination CEX Prototype & AEX QyuSpeed D 0 0.2 0.4 0.6 0.8 1 1.2 0.00 200.00 400.00 600.00 800.00 1000.00 C/C0 Load IgG(mg/mL-ad) CEX Monomer Dimer ≧Trimer HCP protein A 0 0.2 0.4 0.6 0.8 1 1.2 0 1000 2000 3000 4000 5000 C/C0 Load IgG(mg/mL-ad) AEX Monomer Dimer ≧Trimer HCP Monomer 97.77 % Dimer / ≧Trimer 1.32 % / 0.91 % HCP 390 ppm Protein A 0.5 ppm Loading to CEX Flow Through of CEX Flow Through of AEX - 79 % - 35 % - 80 % Monomer 99.54 % Dimer / ≧Trimer 0.33 % / 0.14 % HCP 254 ppm Protein A 0.1 ppm Monomer Recovery: 87 % Monomer 99.79 % Dimer / ≧Trimer 0.21 % / < DL HCP 6 ppm Protein A < 0.1 ppm Monomer Recovery: 99 % - 55 % - 98 %
  • 86. 86 Combination CEX Prototype & AEX QyuSpeed D Monomer 97.6 % Dimer / ≧Trimer 1.79 % / 0.56 % HCP 349 ppm Protein A 3.6 ppm Loading to CEX Flow Through of CEX Flow Through of AEX - 88 % - 20 % - 83 % Monomer 99.66 % Dimer / ≧Trimer 0.28 % / < DL HCP 279 ppm Protein A 0.6 ppm Monomer Recovery: 95 % Monomer 99.75 % Dimer / ≧Trimer 0.18 % / < DL HCP < 1 ppm Protein A 0.1 ppm Monomer Recovery: 99 % - 35 % - 99 % - 83 % 0 0.2 0.4 0.6 0.8 1 1.2 0 200 400 600 800 1000 C/C0 Load IgG(mg/mL-ad) CEX (NCX) Monomer Dimer >Trimer HCP Protein A 0 0.2 0.4 0.6 0.8 1 1.2 0 1000 2000 3000 4000 C/C0 Load IgG(mg/mL-ad) AEX (QSD) Monomer Dimer HCP Protein A
  • 87. 87 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) Loading: 1041 mg/mL-MV MAb: 2.6 mg/mL Flow rate: 6 BV/min Titration pH 7.8 AEX QyuSpeed D (FT) Loading: 4156 mg/mL-MV MAb: 2.08 mg/ml Flow rate: 6 BV/min Aggregate addition Clarification Monomer 97.6 % Dimer / ≧Trimer 1.79 % / 0.56 % HCP 349 ppm Protein A 3.6 ppm Loading to CEX CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL Titration pH 7.0 Elution buffer 25mM Acetate; pH 3.4
  • 88. 88 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) Loading: 1041 mg/mL-MV MAb: 2.6 mg/mL Flow rate: 6 BV/min Titration pH 7.8 AEX QyuSpeed D (FT) Loading: 4156 mg/mL-MV MAb: 2.08 mg/ml Flow rate: 6 BV/min Aggregate addition Clarification Monomer 97.6 % Dimer / ≧Trimer 1.79 % / 0.56 % HCP 349 ppm Protein A 3.6 ppm Loading to CEX Flow Through of CEX - 88 % - 20 % CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL - 83 % Monomer 99.66 % Dimer / ≧Trimer 0.28 % / < DL HCP 279 ppm Protein A 0.6 ppm Monomer Recovery: 95 % Titration pH 7.0 Elution buffer 25mM Acetate; pH 3.4
  • 89. 89 Combination CEX Prototype & AEX QyuSpeed D Protein A (BE) CEX prototype (FT) Loading: 1041 mg/mL-MV MAb: 2.6 mg/mL Flow rate: 6 BV/min Titration pH 7.8 AEX QyuSpeed D (FT) Loading: 4156 mg/mL-MV MAb: 2.08 mg/ml Flow rate: 6 BV/min Aggregate addition Clarification Monomer 97.6 % Dimer / ≧Trimer 1.79 % / 0.56 % HCP 349 ppm Protein A 3.6 ppm Loading to CEX Flow Through of CEX Flow Through of AEX - 88 % - 20 % CHO culture MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL - 83 % Monomer 99.66 % Dimer / ≧Trimer 0.28 % / < DL HCP 279 ppm Protein A 0.6 ppm Monomer Recovery: 95 % Monomer 99.75 % Dimer / ≧Trimer 0.18 % / < DL HCP < 1 ppm Protein A 0.1 ppm Monomer Recovery: 99 % - 35 % - 99 % Titration pH 7.0 - 83 % Elution buffer 25mM Acetate; pH 3.4